Invention Grant
US08410123B2 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
有权
嘧啶磺酰胺衍生物作为趋化因子受体调节剂
- Patent Title: Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent Title (中): 嘧啶磺酰胺衍生物作为趋化因子受体调节剂
-
Application No.: US13336269Application Date: 2011-12-23
-
Publication No.: US08410123B2Publication Date: 2013-04-02
- Inventor: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Neal Michael Smith , Jeffrey Paul Stonehouse , Cherylin Francis Preston
- Applicant: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Neal Michael Smith , Jeffrey Paul Stonehouse , Cherylin Francis Preston
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Fish & Richardson P.C.
- Priority: GB0419235.7 20040828; GB0502544.0 20050208
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P11/06 ; C07D403/12
Abstract:
A compound of formula (I), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
Public/Granted literature
- US20120157431A1 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators Public/Granted day:2012-06-21
Information query
IPC分类:
